Regulatory Expertise LSSI specializes in FDA, ISO, EU, CAN, AUS and Brazil regulatory compliance, offering remediation of FDA 483s and consent decrees. This presents an opportunity to target mid-size device and pharma firms facing regulatory backlogs or post-audit remediation needs.

NPD and Design Controls Strong capabilities in New Product Development, Design Controls and risk management position LSSI to pursue clients launching new medical devices, IVDs or combination products that require end-to-end development and regulatory alignment.

Quality and IT Transformation Service offerings include IT systems and ERP implementation and validation, indicating potential cross-sell to manufacturers needing quality systems, process improvements, and supplier controls integrated with enterprise platforms.

Limited yet Focused Scale Small team (2-10 employees) with <$1M revenue implies a boutique, high-touch advisory model. This can be attractive to startups or smaller manufacturers seeking agile, hands-on regulatory and quality leadership without large firm overhead.

Competitive Positioning Target markets include medical device, IVD, and pharma players, with established peers like Medpace and IQVIA as benchmarks. Leverage niche regulatory remediation and compliance expertise to win mid-tier clients seeking specialized partners.